Original Source: In Vitro Diagnostics Market
Buy Now: Market Research
Dallas, TX: ReportsandReports announce it will carry Belgium In Vitro Diagnostics Market Outlook to 2016 Market Research Report in its Store.
GlobalData’s new report, “Belgium In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Belgium In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Belgium In Vitro Diagnostics (IVD) market.
- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Belgium In Vitro Diagnostics (IVD) competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Browse complete report: Belgium In Vitro Diagnostics Market Outlook to 2016
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In Belgium
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, Belgium, Overall Revenue ($m), 2002-2016
3.3 In Vitro Diagnostics Market, Belgium, Revenue Mix ($m), 2009
3.4 In Vitro Diagnostics Market, Belgium, Category Contribution (%), 2009
3.5 In Vitro Diagnostics, Belgium, Company Share (2008-2009)
4 Clinical Chemistry In Belgium
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, Belgium, Revenue Mix ($m), 2009
4.3 Clinical Chemistry Market, Belgium, Category Contribution (%), 2009
4.4 Clinical Chemistry Overall Revenue (2002-2016)
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016)
4.4.2 Urine Analysis Revenue (2002-2016)
4.5 Clinical Chemistry Distribution Share (2008-2009)
4.6 Clinical Chemistry, Belgium, Company Share (2008-2009)
5 Genetic Testing In Belgium
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, Belgium, Revenue Mix ($m), 2009
5.3 Genetic Testing Market, Belgium, Category Contribution (%), 2009
5.4 Genetic Testing Overall Revenue (2002-2016)
5.5 Genetic Testing Distribution Share (2008-2009)
5.6 Genetic Testing, Belgium, Company Share (2008-2009)
6 Haematology In Belgium
6.1 Haematology, Market Segmentation
6.2 Haematology Market, Belgium, Revenue Mix ($m), 2009
6.3 Haematology Market, Belgium, Category Contribution (%), 2009
6.4 Haematology Overall Revenue (2002-2016)
6.4.1 Haematology Reagents Revenue (2002-2016)
6.4.2 Immunohaematology Revenue (2002-2016)
6.4.3 Haemostasis Revenue (2002-2016)
6.4.4 Haematology Rapid Tests Revenue (2002-2016)
6.4.5 Haematology Cell Counters Revenue (2002-2016)
6.5 Haematology Distribution Share (2008-2009)
6.6 Haematology, Belgium, Company Share (2008-2009)
7 Histology And Cytology In Belgium
7.1 Histology and Cytology, Market Segmentation
7.2 Histology And Cytology Market, Belgium, Revenue Mix ($m), 2009
7.3 Histology and Cytology Market, Belgium, Category Contribution (%), 2009
7.4 Histology And Cytology Overall Revenue (2002-2016)
7.4.1 Histology Revenue (2002-2016)
7.5 Histology And Cytology Distribution Share (2008-2009)
7.6 Histology And Cytology, Belgium, Company Share (2008-2009)
8 Immuno Chemistry In Belgium
8.1 Immuno Chemistry, Market Segmentation
8.2 Immuno Chemistry Market, Belgium, Revenue Mix ($m), 2009
8.3 Immuno Chemistry Market, Belgium, Category Contribution (%), 2009
8.4 Immuno Chemistry Overall Revenue (2002-2016)
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016)
8.4.2 Drug Related Testing Revenue (2002-2016)
8.4.3 Endocrinology Tests Revenue (2002-2016)
8.4.4 Immunochemistry Analyzers Revenue (2002-2016)
8.5 Immuno Chemistry Distribution Share (2008-2009)
8.6 Immuno Chemistry, Belgium, Company Share (2008-2009)
9 Infectious Immunology In Belgium
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, Belgium, Revenue Mix ($m), 2009
9.3 Infectious Immunology Market, Belgium, Category Contribution (%), 2009
9.4 Infectious Immunology Overall Revenue (2002-2016)
9.5 Infectious Immunology Distribution Share (2008-2009)
9.6 Infectious Immunology, Belgium, Company Share (2008-2009)
10 Microbiology Culture In Belgium
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, Belgium, Revenue Mix ($m), 2009
10.3 Microbiology Culture Market, Belgium, Category Contribution (%), 2009
10.4 Microbiology Culture Overall Revenue (2002-2016)
10.4.1 Microbiology Analyzers Revenue (2002-2016)
10.5 Microbiology Culture Distribution Share (2008-2009)
10.6 Microbiology Culture, Belgium, Company Share (2008-2009)
11 Overview of Key Companies in Belgium In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Share in the Belgium In Vitro Diagnostics Market
11.2 Siemens Healthcare
11.2.1 Company Overview
11.2.2 Share in the Belgium In Vitro Diagnostics Market
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Share in the Belgium In Vitro Diagnostics Market
11.4 bioMerieux S.A.
11.4.1 Company Overview
11.4.2 Share in the Belgium In Vitro Diagnostics Market
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Company Overview
11.5.2 Share in the Belgium In Vitro Diagnostics Market
11.6 Beckman Coulter, Inc.
11.6.1 Company Overview
11.6.2 Share in the Belgium In Vitro Diagnostics Market
11.7 Inverness Medical Innovations, Inc.
11.7.1 Company Overview
11.8 Becton, Dickinson and Company
11.8.1 Company Overview
11.9 Hologic, Inc.
11.9.1 Company Overview
11.10 OLYMPUS CORPORATION
11.10.1 Company Overview
11.11 Sysmex Corporation
11.11.1 Company Overview
11.12 Ortho-Clinical Diagnostics Inc.
11.12.1 Company Overview
11.13 DiaSorin S.p.A
11.13.1 Company Overview
11.14 Qiagen N.V.
11.14.1 Company Overview
11.15 Gen-Probe Incorporated
11.15.1 Company Overview
11.16 Phadia AB
11.16.1 Company Overview
11.17 Innogenetics NV
11.17.1 Company Overview
11.18 BioTech Tools
11.18.1 Company Overview
11.19 Immunosource
11.19.1 Company Overview
11.20 CorisBioConcept SPRL
11.20.1 Company Overview
11.21 MabCure Inc.
11.21.1 Company Overview
12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology and Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products
13 Financial Deals Landscape
13.1 Partnerships
13.1.1 QIAGEN Enters Into Distribution Agreement With Celera
13.1.2 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University
13.1.3 DiaGenic Enters Into Distribution Agreement With Ferrer inCode
13.1.4 OraSure Technologies Enters Into An Agreement With Roche Diagnostics
13.1.5 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal
13.1.6 Radient Pharmaceuticals Enters Into An Agreement With GenWay Biotech
14 Recent Developments
14.1 Strategy and Business Planning
14.1.1 Jun 22, 2010: Ablynx Expands Into New R&D Facilities In Belgium
14.1.2 Dec 08, 2009: Genetix Expands Sales, Support And Service Organization In France And Benelux
14.2 Product News
14.2.1 May 27, 2010: Applied BioCode Receives CE Mark Certification For BioCode-1000 Analyzer
15 Appendix
15.1 Definitions of Markets Covered in the Report
15.1.1 In Vitro Diagnostics
15.2 Research Methodology
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panels
15.8 GlobalData Consulting
15.9 Currency Conversion
15.10 Contact Us
15.11 Disclaimer
Browse complete report: Belgium In Vitro Diagnostics Market Outlook to 2016
Browse all Medical Devices Market Research Reports
Browse all GlobalData Market Research Reports
Browse all Newly Published Market Research Reports
Related Reports:
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
